Significant increase of the turnover as of September 2022 compared with last year third quarter
Press Release Ecully, October 14, 2022 – 8 am Nine-month turnover of €5.4 million, up 82% Sales double in...
Staff
Pierce County Alliance Celebrates 50th Anniversary Serving the Pacific Northwest in Substance Abuse Treatment
TACOMA, Wash., Oct. 13, 2022 (GLOBE NEWSWIRE) -- Pierce County Alliance (PCA), founded in 1972, will celebrate its 50th Anniversary...
Biomerica Reports 30% Increase in Revenues for Fiscal Q1 2023 vs. Fiscal Q1 2022
Notice of Patent Allowance in Australia containing broad claims pertaining to treating ADD/ADHD using the InFoods®Technology Notice of Patent Allowance...
Enliven Therapeutics and Imara Announce Merger Agreement
Merger to create Nasdaq-listed, clinical-stage biopharmaceutical company focused on advancing Enliven’s portfolio of precision oncology programsCombined company is expected to...
Kane Biotech to Present at Symposium on Advanced Wound Care Fall Forum
Company presenting technologies for improving patient outcomes in wound careWINNIPEG, Manitoba, Oct. 13, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc....
Profound Medical to Release Third Quarter 2022 Financial Results on November 3 – Conference Call to Follow
TORONTO, Oct. 13, 2022 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device...
Kymera Therapeutics to Hold Investor Webcast on December 14 to Share Clinical Data from KT-474 Phase I Patient Cohort and Oncology Pipeline
Dosing in KT-474 Phase 1 HS and AD patient cohort (Part C) complete KT-413 and KT-333 continuing in Phase 1...
Seer to Report Third Quarter 2022 Financial Results on November 8, 2022
REDWOOD CITY, Calif., Oct. 13, 2022 (GLOBE NEWSWIRE) -- Seer, Inc. (NASDAQ: SEER), a life sciences company commercializing a disruptive...
ERYTECH Announces Receipt of Nasdaq Notice
ERYTECH Announces Receipt of Nasdaq Notice Cambridge, MA (U.S.) and Lyon (France), October 13, 2022 – ERYTECH Pharma (Nasdaq &...
Travere Therapeutics Provides Regulatory Update on its Sparsentan Program for IgA Nephropathy
Conference call and webcast to be held at 4:30p.m. ET SAN DIEGO, Oct. 13, 2022 (GLOBE NEWSWIRE) -- Travere Therapeutics,...
Paratek Pharmaceuticals Presenting New Data for NUZYRA® (omadacycline) at IDWeek 2022
Highlights include data from non-clinical and microbiology programs and real-world patient use BOSTON, Oct. 13, 2022 (GLOBE NEWSWIRE) -- Paratek...
IO Biotech Announces Appointment of New Chief Financial Officer
NEW YORK, Oct. 13, 2022 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer...
ResMed to Report First Quarter Fiscal 2023 Earnings on October 27, 2022
SAN DIEGO, Oct. 13, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial...
WW Schedules Third Quarter 2022 Earnings Conference Call
NEW YORK, Oct. 13, 2022 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“WeightWatchers,” “WW,” or “the Company”) will release...
Eargo Announces Record Date for Proposed Rights Offering
Record Date established as October 24, 2022To be a stockholder of record, investors are advised to own EAR stock by...
Invivyd Appoints Fred Driscoll as Interim Chief Financial Officer and Announces Resource Reallocation to Maximize Integrated Discovery Platform
WALTHAM, Mass., Oct. 13, 2022 (GLOBE NEWSWIRE) -- Invivyd, (Nasdaq: IVVD) a clinical-stage biopharmaceutical company on a mission to protect...
BridgeBio Pharma Presents Updated Positive Data from its BBP-812 Canavan Disease Gene Therapy Program at the 51st Annual Meeting of the Child Neurology Society
- Robust post-dosing changes continue to be seen in key markers associated with severity of disease - Pharmacodynamic data from...
Sanofi: Information concerning the total number of voting rights and shares – September 2022
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code...
PathSpot Unveils Handwashing Data From Millions Of Scans In Honor Of Global Handwashing Day
PathSpot scans prove 75% of people do not wash their hands enough; touching money and fake nails contribute the most...
Vystar’s Subsidiary, Rotmans going out of business as Steve Rotman retires from Rotmans Furniture
New England’s largest furniture and flooring store begins liquidation October 14 WORCESTER, Mass., Oct. 13, 2022 (GLOBE NEWSWIRE) -- Vystar®...